144 related articles for article (PubMed ID: 38214337)
1. Clinical characteristics and risk factors for late-onset pneumocystis jirovecii pneumonia in kidney transplantation recipients.
Zhu X; Xie M; Fan J; Geng B; Fei G; Zhou Q; Wu H; Liu X; Jiang X
Mycoses; 2024 Jan; 67(1):e13688. PubMed ID: 38214337
[TBL] [Abstract][Full Text] [Related]
2. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
Yang P; Zhu X; Liang W; Cai R
Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
[TBL] [Abstract][Full Text] [Related]
4. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW
Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for Pneumocystis jirovecii pneumonia after kidney transplantation: A systematic review and meta-analysis.
Cheng B; Qi C; Zhang S; Wang X
Clin Transplant; 2024 May; 38(5):e15320. PubMed ID: 38690617
[TBL] [Abstract][Full Text] [Related]
6. Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study.
Lee G; Koo TY; Kim HW; Lee DR; Lee DW; Oh J; Kim BS; Kim MS; Yang J;
Sci Rep; 2022 Jun; 12(1):10682. PubMed ID: 35739203
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
8. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
[TBL] [Abstract][Full Text] [Related]
9. Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
Brakemeier S; Dürr M; Bachmann F; Schmidt D; Gaedeke J; Budde K
Transplant Proc; 2016 Nov; 48(9):2924-2930. PubMed ID: 27932109
[TBL] [Abstract][Full Text] [Related]
10. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
[TBL] [Abstract][Full Text] [Related]
11. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.
Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L
Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619
[TBL] [Abstract][Full Text] [Related]
12. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study.
Chen RY; Li DW; Wang JY; Zhuang SY; Wu HY; Wu JJ; Qu JW; Sun N; Zhong C; Zhu C; Zhang M; Yu YT; Yuan XD
Int J Infect Dis; 2022 Dec; 125():209-215. PubMed ID: 36243280
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia.
Peng J; Ni M; Du D; Lu Y; Song J; Liu W; Shen N; Wang X; Zhu Y; Vallance BA; Sun Z; Yu HB
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):83. PubMed ID: 34911528
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.
Lee SH; Huh KH; Joo DJ; Kim MS; Kim SI; Lee J; Park MS; Kim YS; Kim SK; Chang J; Kim YS; Kim SY
Sci Rep; 2017 May; 7(1):1571. PubMed ID: 28484270
[TBL] [Abstract][Full Text] [Related]
18. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial Pneumocystis jirovecii pneumonia: lessons from a cluster in kidney transplant recipients.
Phipps LM; Chen SC; Kable K; Halliday CL; Firacative C; Meyer W; Wong G; Nankivell BJ
Transplantation; 2011 Dec; 92(12):1327-34. PubMed ID: 22129760
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of and risk factors for Pneumocystis jirovecii pneumonia in anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody-positive dermatomyositis patients: a single-center retrospective study.
Li J; Wang S; Zheng J; Li Q; Li J; Lu L
Clin Rheumatol; 2023 Feb; 42(2):453-462. PubMed ID: 36301369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
